Summit Therapeutics Inc. Notes Payable, Current
Summit Therapeutics Inc. (SMMT) had Notes Payable, Current of $24.50 million as of 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2024-10-30
- 2024-09-30: Notes Payable, Current $24.50M.
- 2024-09-16: Notes Payable, Current $24.50M.
- 2024-06-30: Notes Payable, Current $100.00M.
- 2023-12-31: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current |
|---|---|
| 2024-09-30 | $24.50M 10-Q · filed 2024-10-30 |
| 2024-09-16 | $24.50M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $100.00M 10-Q · filed 2024-08-06 |
| 2023-12-31 | $0.00 10-Q · filed 2024-10-30 |
| 2023-09-30 | $100.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2022-12-31 | $19.77M 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |